This Monday, Ruihui vaccine was officially launched in the United States, and medical staff from various states in the United States became the first batch of vaccinators. Almost every vaccination site has a lot of journalists squatting. From the news on regular TV stations to the soft and popular social media, vaccines are the hottest topics. The messages conveyed by health officials in various states are very consistent. Vaccines are effective and safe. Everyone hopes that vaccines can end the epidemic, but many people still have concerns about the safety of vaccines. After all, in order to speed up R&D, the clinical trial time has been greatly shortened. It takes at least 2-3 years for normal vaccine development to ensure safety. Sure enough, the vaccine, which had only 3 months of clinical trial, had problems the day after it was launched.
On Tuesday, a medical staff member in Alaska experienced a severe allergic reaction after receiving the Ruihui vaccine, resulting in hospitalization. It is reported that the medical staff is a middle-aged woman with no previous history of allergies. After being hospitalized, her condition has stabilized after treatment and is still under surveillance in the hospital. The healthcare worker received the vaccine at Bartlett Regional Hospital in Alaska. Lindy Jones, director of Bartlett's emergency room, said that ten minutes after the patient was vaccinated, he showed an allergic reaction: his heartbeat was rapid, his breathing was short, and he had a rash and redness. After taking an anti-allergic drug failed, she was admitted to the ICU. Fortunately, she received adrenaline allergy treatment in the shortest time and her condition stabilized. The doctor said her allergic reaction was severe but not life-threatening. "The hospital's statement said she was "still encouraging her colleagues to get vaccinated."
According to the hospital, another male health care worker also had an allergic reaction after receiving the vaccine on Wednesday. However, his reaction was not very serious. Ten minutes after receiving the injection, the man developed symptoms of "swelling eyes, dizziness, and itchy throat". Initially, the mild reaction was not judged as an "allergic reaction". However, he was also treated for adrenaline allergic treatment in the hospital's emergency room. The hospital said: After receiving the treatment, he completely returned to normal within an hour, Are there any hospitalizations? It is said that the healthcare worker hopes that his manager will not have a negative impact on other colleagues, and his colleagues are waiting in line for vaccination. A total of 144 staff members were vaccinated at Bartlett Regional Hospital on Wednesday, with a total of 400 staff members requesting vaccination. Data on the two allergic reactions have been reported to the CDC of the CDC.
and these news broke on Thursday. , which the CDC said was Deputy Director Jay Butler (Jay) Dr. Butler said the two healthcare workers were the first case of allergic to the Pfizer vaccine in the United States. After the FDA approved the Pfizer vaccine for emergency use after clinical trials last Friday. The CDC also said the vaccine was targeted at 18 to 64-year-olds with an effective efficiency of up to 95%. According to data from the Phase 3 clinical trial released by Ruihui, no one of the 44,000 participants experienced any major adverse reactions. After the
vaccine was launched, the CDC said it encouraged all adults to be vaccinated. But allergic cases in Alaska could exacerbate concerns about side effects of the vaccine. Experts say developments could prompt people to demand stricter guidelines to ensure careful monitoring of adverse reactions to recipients. The CDC recommends that the vaccine be aerobic Manage in the environment of supplies such as gas and adrenaline. A doctor from the FDA's Ruihui vaccine expert panel said that vaccination guidance has taken appropriate precautions. For example, it is required that recipients have to stay in place for 15 minutes after getting the vaccine, which is why both patients in Alaska were treated quickly. "I don't think that means we should suspend the distribution of vaccines." However, researchers need to figure out what components of the vaccine cause an allergic reaction.
Similar news came from the UK, which started vaccinating Ruihui vaccine earlier than the United States. Last week, two health workers in the UK had serious adverse reactions after receiving the vaccine. British health officials warned that people with a history of "severe" allergic reactions to vaccines, drugs or food should not be vaccinated with Pfizer's vaccine.Severe allergic reactions can be life-threatening, and patients experience dyspnea and drop in blood pressure, usually within minutes or even seconds of exposure to allergens.
The official attitude of the United States is completely different from that of the United Kingdom, and the vaccine has not been stopped. US FDA officials said that after the vaccine is further used, they will ask Pfizer to increase monitoring of allergic reactions and submit relevant data. The CDC said that people with severe allergies can be vaccinated safely and should be closely monitored for 30 minutes after receiving the injection. Experts predict that similar allergies will definitely happen again. The subtext is not to be afraid, we will take precautions and treat any allergies immediately. In short, the vaccine will not be stopped just because someone is allergic. Everyone should slowly "accustom" to allergic reactions.
In fact, when the vaccine was just approved for marketing on Monday, the editor conducted a small-scale voting survey. Our investigation question is, if the vaccines in the United States are popular and free of charge, will you be willing to get them? The results of the survey conducted by
showed that 25% of people said they would be vaccinated immediately; 70% said they would wait for a while before being vaccinated; while 2% of people were very determined and said they would never be vaccinated.
The editor also interviewed everyone's reasons for giving different answers:
"I will definitely get the vaccine right away. I think in the United States, you can only rely on everyone to get vaccinated to control the epidemic. I think the side effects should not be too serious. When you read the news, you are similar to getting the ordinary flu vaccine. I feel that those particularly serious cases are individual cases. You can't deny the vaccine completely because of individual cases. In addition, many of my friends who work in hospitals are ready to get vaccinated immediately."
From Ms. L
"I don't want to go to the test immediately, mainly because I'm worried about side effects. I've always heard that someone had something to do with the vaccine. I want to wait until the vaccine is more mature before thinking about it. After all, the vaccines in the past took a long time to develop, and this time it was too fast, which makes people feel unsure. When I was in school, a professor in our school was paralyzed because of the vaccine. Although this kind of thing is not likely to happen, I really dare not think about it if it happens to me."
From Z classmate
"I said I didn't give you a shot, but it doesn't mean that I don't trust the vaccine itself. It's mainly because I think the virus will always mutate after all. Even if I get it, if the virus on others has mutated, then I will still be infected after I get the previous vaccine. Since that's the case, why do I still have to take the risk of getting a shot? Let's take a step back, even if I get a shot, I dare not wear a mask when I go out. Anyway, I have to wear a mask, wash my hands and disinfect it all kinds of hands. There is no difference for me whether I'm going to get a shot."
From M Men's
Although due to limited time, the number of people interviewed in the survey is relatively small, but everyone's attitude and reasons still reflect the current ideas of many people about vaccines. After allergic cases were reported, how do you think about the push for the US vaccine? For more information on studying in the United States, please continue to follow us!
